| Target's General Information |
| Target ID |
T11453 |
| Target Name |
Gastric inhibitory polypeptide (GIP) |
| Synonyms |
Glucose-dependent insulinotropic polypeptide; GIP |
| Target Type |
Clinical trial |
| Gene Name |
GIP |
| Biochemical Class |
Glucagon |
| UniProt ID |
GIP_HUMAN |
| Target's Expression Profile in Disease Related Tissue between Patients and Normal People |
| Disease |
Type 2 diabetes |
| Tissue |
Liver tissue |
| Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual |
Fold-change: -0.2
Z-score: -0.76
P-value: 2.54E-01
|
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
| Target's Expression Profile across Various Tissues of Healthy Individual |
|
| References |
| REF 1 |
Interpreting expression profiles of cancers by genome-wide survey of breadth of expression in normal tissues. Genomics 2005 Aug;86(2):127-41.
|
| REF 2 |
NCBI GEO: archive for functional genomics data sets--update. Nucleic Acids Res. 2013 Jan;41(Database issue):D991-5.
|
